Synergistic effect of propranolol and nicotinic acid on the inhibition of plasma free fatty acid release in the dog.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000273:Adipose Tissue / Q000187:drug effects / Q000201:enzymology; D000818:Animals; D003864:Depression, Chemical; D004285:Dogs; D004357:Drug Synergism; D005230:Fatty Acids, Nonesterified / Q000037:antagonists & inhibitors* / Q000097:blood; D000960:Hypolipidemic Agents / Q000494:pharmacology; D007263:Infusions, Parenteral; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D008053:Lipid Mobilization / Q000187:drug effects*; D008055:Lipids / Q000096:biosynthesis; D008099:Liver / Q000378:metabolism; D009539:Nicotinic Acids / Q000494:pharmacology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D011433:Propranolol / Q000494:pharmacology*
D005230:Fatty Acids, Nonesterified; D000960:Hypolipidemic Agents; D007328:Insulin; D008055:Lipids; D009539:Nicotinic Acids; D011433:Propranolol; D000262:Adenylyl Cyclases; D009638:Norepinephrine